Engraftment and survival after unrelated-donor bone marrow transplantation: A report from the national marrow donor program

Blood

Volumn 96, Issue 13, 2000, Pages 4096-4102

  Davies, Stella M ^a   Kollman, Craig ^b   Anasetti, Claudio ^b   Antin, Joseph H ^b   Gajewski, James ^b   Casper, James T ^b   Nademanee, Auayporn ^b   Moreen, Harriet ^b   King, Roberta ^b   Confer, Dennis ^b   Keman, Nancy A ^b  

^a Department of Pediatrics   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; COMORBIDITY; CYTOMEGALIC INCLUSION BODY DISEASE; ETHNIC GROUP; FEMALE; GENETIC DISORDER; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HISTOCOMPATIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LEUKEMIA; LIFE TABLE; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NEOPLASM; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STATISTICS; SURVIVAL; THROMBOCYTE COUNT; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; COMORBIDITY; CYTOMEGALOVIRUS INFECTIONS; ETHNIC GROUPS; FEMALE; GENETIC DISEASES, INBORN; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HISTOCOMPATIBILITY; HUMANS; IMMUNOSUPPRESSION; INFANT; LEUKEMIA; LIFE TABLES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PLATELET COUNT; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION CONDITIONING; UNITED STATES;

EID: 0034672165     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.13.4096     Document Type: Article

References (17)

1. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplants from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993:328:593-602.
2. Anasetti C, Ams D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989:320:197-204.
3. Ash RC, Horowitz MM, Gale RP, et al. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T-depletion. Bone Marrow Transplant. 1991;7:443-452.
4. Szydio R, Goldman J, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J CIin Oncol. 1997:15:1767-1777.
5. Stroncek D, Bartsch G, Perkins HA, et al. The National Marrow Donor Program. Transfusion. 1993:33:567-577.
6. Perkins HA, Hansen JA. The US National Marrow Donor Program. Am J Pediatr Hematol Oncol. 1994:16:30-34.
7. Sullivan KM. Graft-versus-host disease. In: Thomas ED, Blume KG, Forman SJ, eds. Hemalopoietic Cell Transplantation. 2nd ed. Maiden, MA: Blackwell Science; 1999:518-519.
8. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Slat Med. 1999:18:695-706.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
10. Mantel M. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966:50:163-170.
11. Cox DR. Regression models and life tables. J R Stat Soc B. 1972:34:187-220.
12. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985:313: 765-771.
13. Davies SM, Ramsay NKC, Haake RJ, et al. Comparison of engraftment in recipients of matched sibling or unrelated donor marrow allografts. Bone Marrow Transplant 1994:13:51-57.
14. Kernan NA, Bordignon C, Heller G, et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: 1. analysis of risk factors and results of secondary transplants. Blood. 1989;74:2227-2236.
15. Sierra J, Storer B, Hansen JH, et al. Transplantation of marrow cells from unrelated donors for treatment of high risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood. 1997;89:4226-4235.
16. Balduzzi A, Gooley T, Anasetti C, et al. Unrelated donor marrow transplantation in children. Blood. 1995:86:3247-3256.
17. Sullivan KM, Witherspoon RP, Storb R, et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood. 1988;72:546-554.